Skip to main content
Premium Trial:

Request an Annual Quote

SAS Launches Life Science Unit

NEW YORK, March 31 - SAS today announced the launch of a new business unit dedicated to the life sciences market.

 

The new Life Sciences Organization is led by Kecia Serwin, who was formerly a sales director at the company. It will support healthcare providers, health insurers, and pharmaceutical, biotechnology and medical device companies.

 

The company has already identified several projects that the Life Sciences Organization will oversee, including support for biomedical customers in complying with the Food and Drug Administration's 21 CFR Part 11 regulations for the authentication of electronic documents. To meet this demand, SAS said that the Life Sciences Organization has launched the so-called Migration, Integration, and Validation (MIV) project to identify and address migration, integration, and validation issues related to achieving CFR Part 11 compliance.

 

For further information, see the press release.

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.